首页 工具
登录

搜索结果

Search Results for "Azido-PEG5-Ala-Ala-Asn-PAB"
Targets Recommended: Others

1

抑制剂 & 化合物

152

化合物库

6

TargetMol 试剂盒

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

Cat. No. Product Name
CL0121 ALK inhibitor kit

L6300 药食同源库

1088 compounds
A unique collection of 1088 compounds from food as medicine for high throughput and high content screening;
L8710 铜死亡化合物库

411 compounds
TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases.
L2620 神经退行性疾病化合物库

1622 compounds
A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS;
L3400 临床期小分子药物库

3142 compounds
A unique collection of 3142 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
L9210 儿童药物库

1015 compounds
A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening.
L5400 抗心血管疾病化合物库

1428 compounds
A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L4200 FDA 上市药物库

1729 compounds
1729个FDA批准药物的独特集合,可用于高通量筛选和高内涵筛选;
L2000 抑制剂库

7618 compounds
A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L3100 造血毒性小分子库

104 compounds
A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;
L4520 抗菌活性库

921 compounds
A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;
L4660 神经疾病库Plus

1246 compounds
Well-chosen 1246 compounds with unique structures targeting nervous system;
L2192 抗胰腺癌化合物库

2267 compounds
A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS;
L1600 激酶抑制剂库

2230 compounds
A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases;
L1310 细胞骨架化合物库

590 compounds
A unique collection of 590 cytoskeleton-related compounds, can be used for HTS and HCS;
L6010 天然产物库

3720 compounds
A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS);
L8500 HIF-1化合物库

1352 compounds
A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies;
L2910 抗氧化化合物库

1040 compounds
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of a...
L7300 钾通道分子库

160 compounds
A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening;
L6500 微生物天然产物库

254 compounds
254种微生物来源的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选;
L2521 糖酵解化合物库

560 compounds
560 glycolysis-related active compounds for high-throughput and high-content screening.
L9820 β-内酰胺类化合物库

105 compounds
A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS;
L2130 抗癌细胞代谢库

1280 compounds
A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
L6700 抗癌天然产物库

1800 compounds
A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L1000 上市药物库

2863 compounds
A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS);
L2560 代谢化合物库

2350 compounds
A unique collection of 2350 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L2140 癌细胞分化化合物库

413 compounds
A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening;
L2600 神经信号分子库

2011 compounds
A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L5100 含氟化合物库

583 compounds
A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);
L8400 血液病分子库

524 compounds
A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);
L4600 植物来源化合物库

3076 compounds
A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);
L3300 组胺&褪黑色素化合物库

155 compounds
A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L2191 抗乳腺癌化合物库

1965 compounds
A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study;
L1010 FDA上市及药典收录分子库

3158 compounds
3158个上市及药典分子集合,可用于高通量筛选和高内涵筛选;
L8000 干细胞分化化合物库

1213 compounds
A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening;
L6120 黄酮类天然产物库

477 compounds
A unique collection of 477 flavonoids can be used for high throughput and high content screening;
L2100 抗癌化合物库

6854 compounds
A unique collection of 6854 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L2610 神经递质受体化合物库

1513 compounds
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening;
L4020 NO PAINS 化合物库

9555 compounds
L5510 肝脏毒性化合物库

1040 compounds
A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening;
L4000 经典已知活性库

12862 compounds
TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 12862 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research.
NY1000 天然产物衍生物库

4000 compounds
The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold).
L4010 已知活性化合物库

20980 compounds
A collection of 20980 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.
L6810 中药单体化合物库

2688 compounds
A unique collection of 2688 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism;
L9300 大环化合物库

216 compounds
216种活性已知的大环化合物,用于高通量、高内涵筛选;
L1300 PI3K/Akt/mTOR 化合物库

425 compounds
A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;
L6030 天然产物衍生物虚筛化合物库

DP9200 DGK抑制剂库

L2510 脂代谢化合物库

496 compounds
A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
L4510 抗寄生虫库

336 compounds
336 well-chosen unique anti-parasitic small molecules;
L5800 药物代谢杂质库

200 compounds
A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);
L6600 胃肠炎天然产物库

223 compounds
A unique collection of 223 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);
L6100 天然多酚类化合物库

640 compounds
A unique collection of 640 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);
L2195 抗前列腺癌化合物库

2096 compounds
2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.
L5300 线粒体靶向库

447 compounds
A unique collection of 447 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;
L9700 内质网应激化合物库

193 compounds
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);
L3200 自噬库

1248 compounds
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L9200 药物功能重定位化合物库

4240 compounds
A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
L7400 钠通道分子库

128 compounds
A unique collection of 128 sodium channel blockers and agonists for high throughput and high content screening;
L6900 稀有天然产物库

284 compounds
A unique collection of 284 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);
L1720 核苷类化合物库

337 compounds
A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;
L6110 生物碱类天然产物库

468 compounds
A unique collection of 468 natural alkaloids can be used for high throughput and high content screening;
L2540 肠道微生物代谢化合物库

352 compounds
A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS;
L7700 神经再生化合物库

529 compounds
A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;
L4800 血管生成库

1370 compounds
A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
L2900 氧化还原化合物库

1279 compounds
1279 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.
L1800 抗感染化合物库

2977 compounds
A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;
L4700 免疫/炎症分子化合物库

3483 compounds
A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening.
L1610 FDA 上市激酶抑制剂库

280 compounds
Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research.
L9000 细胞凋亡化合物库

1796 compounds
A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;
L9500 表型筛选靶点鉴定库

1832 compounds
A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening;
L6730 抗病毒中药单体化合物库

270 compounds
A collection of 270 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies.
L1110 微管靶向化合物库

80 compounds
A unique collection of 80 microtubule-targeted compounds can be used in HTS and HCS;
L4500 抗真菌库

253 compounds
A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.
L8600 泛素化化合物库

214 compounds
A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening;
L3800 NF-κB 通路分子库

560 compounds
A unique collection of 560 compounds targeting NF-κB signaling for high throughput screening and high content screening;
L9860 抗抑郁症化合物库

1181 compounds
1181 compounds associated with depression that can be used for high-throughput and high-content screening
L2800 5-羟色胺分子库

275 compounds
A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening;
L9830 抗帕金森病化合物库

908 compounds
A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.
L8110 细胞重编程化合物库

1840 compounds
A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L4300 Wnt/Hedgehog/Notch 通路化合物库

240 compounds
A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;
L6160 Ro5类药天然产物库

2743 compounds
A unique collection of 2743 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening;
L4400 抗生素库

708 compounds
A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening;
L3510 甲基化化合物库

131 compounds
131 methylation-related compounds that can be used for high-throughput and high-content screening.
L9400 PPI抑制剂库

260 compounds
A unique collection of 260 PPI-related compounds for drug screening;
L2170 肿瘤免疫治疗小分子化合物库

454 compounds
A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening;
L2193 抗肝癌化合物库

1816 compounds
1816 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.
L8720 细胞焦亡化合物库

1077 compounds
1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening.
L9600 多肽分子库

533 compounds
533 peptides can be used in peptide drug development and signaling transduction and mechanism study;
L1510 核受体化合物库

420 compounds
A unique collection of 420 nuclear receptor signaling targeted compounds for high throughput and high content screening;
L2550 谷氨酰胺代谢化合物库

580 compounds
A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;
L6710 中药抗炎分子库

1260 compounds
A collection of 1260 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study;
L6130 萜类天然产物库

349 compounds
A unique collection of 349 natural terpenes and terpenoids can be used for high throughput and high content screening;
L2194 抗结直肠癌化合物库

1565 compounds
1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.
L6140 糖类及苷类化合物库

364 compounds
A unique collection of 364 saccharides and glycosides compounds can be used for HTS and HCS;
L1200 表观遗传库

960 compounds
Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1580 GPCR库Plus

338 compounds
Well-chosen 338 GPCR targeting compounds with unique structures;
L2570 人代谢物化合物库

4532 compounds
A unique collection of 4532 human metabolites for high-throughput, high-content screening.
L1500 GPCR靶点分子库

1633 compounds
A unique collection of 1633 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;
L6020 天然产物单体化合物库

L1120 AMPK靶向分子库

64 compounds
64 well-chosen unique AMPK-targeted small molecules;
L6800 中国药典收录天然产物库

2070 compounds
A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;
L7600 趋化因子抑制剂库

59 compounds
A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;
L9420 外泌体相关化合物库

54 compounds
54 exosome-related compounds that can be used for high-throughput and high-content screening.
L9810 抗纤维化化合物库

1180 compounds
A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS;
L2400 内分泌激素分子库

813 compounds
A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L6620 抗寄生虫天然产物库

233 compounds
A unique collection of 233 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS);
L6200 瑶药化合物库

225 compounds
A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening.
L7870 可溶性羧酸片段化合物库

1807 compounds
L6150 天然产物共价化合物库

596 compounds
Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.
L7850 高溶解性3D结构多样性片段化合物库

1081 compounds
The library of highly soluble 3D structural diversity fragments contains 1081 compounds.
L6740 抗结直肠癌中药单体化合物库

386 compounds
A collection of 386 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies.
L9410 共价抑制剂库

941 compounds
A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc.
L8300 染色质修饰分子库

256 compounds
A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);
L4100 TGF-β/Smad靶点化合物库

180 compounds
A unique collection of 180 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;
L3700 JAK-STAT 化合物库

256 compounds
A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening;
L6220 蒙药化合物库

960 compounds
A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening.
L6000 高通量筛选天然产物库

4320 compounds
A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen
L2700 肾上腺素能受体化合物库

219 compounds
A unique collection of 219 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;
L6610 抗感染天然产物库

1070 compounds
A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);
L7200 钙通道分子库

143 compounds
A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening;
L2500 人内源代谢化合物库

1400 compounds
A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening;
L1900 抗糖尿病库

690 compounds
A unique collection of 690 diabetes related compounds;
L2520 糖代谢化合物库

708 compounds
708 glycometabolism-related comounds, can be used for HTS and HCT;
L6720 抗COVID-19中药单体库

1162 compounds
A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening;
L5700 精选片段库

246 compounds
A unique collection of 246 fragment-like small molecules for FBDD;
L5500 毒性化合物库

277 compounds
A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS);
L1380 转录因子库

704 compounds
Well-chosen 704 compounds with unique structures targeting transcription factor;
L7100 抗肥胖化合物库

1359 compounds
A unique collection of 1359 anti-obesity compounds for high throughput and high content screening;
L1700 抗病毒库

800 compounds
A unique collection of 800 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;
L2200 酪氨酸激酶分子库

746 compounds
A unique collection of 746 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;
L3500 组蛋白修饰化合物库

362 compounds
A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);
L9610 环肽库

58 compounds
58 species of cyclic peptide molecules for high-throughput and high-content screening;
L6400 海洋天然产物库

94 compounds
A unique collection of 94 marine natural products for high throughput screening (HTS) and high content screening (HCS);
L1400 MAPK 抑制剂库

367 compounds
A unique collection of 367 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;
L1710 抗COVID-19化合物库

1160 compounds
A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents;
L2300 离子通道库

946 compounds
A unique collection of 946 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;
L2160 抗癌活性化合物库

2439 compounds
A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L3600 细胞因子抑制剂库

613 compounds
A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;
L2150 抗癌药物库

2900 compounds
A unique collection of 2900 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
L7000 活性脂质化合物库

385 compounds
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa
L8700 铁死亡化合物库

800 compounds
A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study;
L8100 细胞周期化合物库

695 compounds
A unique collection of 695 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);
L8200 抗衰老化合物库

3324 compounds
A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);
L8800 药物片段库

1158 compounds
1158 drug fragments,a must-have tool for FBDD;
L2110 抗癌上市药物库

1806 compounds
A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
L5900 血脑屏障通透化合物库

516 compounds
A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);
L6210 藏药化合物库

754 compounds
A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.
L2180 抗肿瘤库Plus

1468 compounds
Well-chosen 1468 anti-tumor compounds with unique structures;
L1100 蛋白酶抑制剂库

344 compounds
A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening;
L7900 成骨分子库

320 compounds
A unique collection of 320 osteogenesis related compounds for high throughput and high content screening;
L9840 抗阿尔茨海默症化合物库

1040 compounds
A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.

化合物库

ALK inhibitor kit
CL0121
Compounds: 0
药食同源库
L6300
Compounds: 1088
铜死亡化合物库
L8710
Compounds: 411
神经退行性疾病化合物库
L2620
Compounds: 1622
临床期小分子药物库
L3400
Compounds: 3142
儿童药物库
L9210
Compounds: 1015
抗心血管疾病化合物库
L5400
Compounds: 1428
FDA 上市药物库
L4200
Compounds: 1729
抑制剂库
L2000
Compounds: 7618
造血毒性小分子库
L3100
Compounds: 104
抗菌活性库
L4520
Compounds: 921
神经疾病库Plus
L4660
Compounds: 1246
抗胰腺癌化合物库
L2192
Compounds: 2267
激酶抑制剂库
L1600
Compounds: 2230
细胞骨架化合物库
L1310
Compounds: 590
天然产物库
L6010
Compounds: 3720
HIF-1化合物库
L8500
Compounds: 1352
抗氧化化合物库
L2910
Compounds: 1040
钾通道分子库
L7300
Compounds: 160
微生物天然产物库
L6500
Compounds: 254
糖酵解化合物库
L2521
Compounds: 560
β-内酰胺类化合物库
L9820
Compounds: 105
抗癌细胞代谢库
L2130
Compounds: 1280
抗癌天然产物库
L6700
Compounds: 1800
上市药物库
L1000
Compounds: 2863
代谢化合物库
L2560
Compounds: 2350
癌细胞分化化合物库
L2140
Compounds: 413
神经信号分子库
L2600
Compounds: 2011
含氟化合物库
L5100
Compounds: 583
血液病分子库
L8400
Compounds: 524
植物来源化合物库
L4600
Compounds: 3076
组胺&褪黑色素化合物库
L3300
Compounds: 155
抗乳腺癌化合物库
L2191
Compounds: 1965
FDA上市及药典收录分子库
L1010
Compounds: 3158
干细胞分化化合物库
L8000
Compounds: 1213
黄酮类天然产物库
L6120
Compounds: 477
抗癌化合物库
L2100
Compounds: 6854
神经递质受体化合物库
L2610
Compounds: 1513
NO PAINS 化合物库
L4020
Compounds: 9555
肝脏毒性化合物库
L5510
Compounds: 1040
经典已知活性库
L4000
Compounds: 12862
天然产物衍生物库
NY1000
Compounds: 4000
已知活性化合物库
L4010
Compounds: 20980
中药单体化合物库
L6810
Compounds: 2688
大环化合物库
L9300
Compounds: 216
PI3K/Akt/mTOR 化合物库
L1300
Compounds: 425
天然产物衍生物虚筛化合物库
L6030
Compounds: 0
DGK抑制剂库
DP9200
Compounds: 0
脂代谢化合物库
L2510
Compounds: 496
抗寄生虫库
L4510
Compounds: 336
药物代谢杂质库
L5800
Compounds: 200
胃肠炎天然产物库
L6600
Compounds: 223
天然多酚类化合物库
L6100
Compounds: 640
抗前列腺癌化合物库
L2195
Compounds: 2096
线粒体靶向库
L5300
Compounds: 447
内质网应激化合物库
L9700
Compounds: 193
自噬库
L3200
Compounds: 1248
药物功能重定位化合物库
L9200
Compounds: 4240
钠通道分子库
L7400
Compounds: 128
稀有天然产物库
L6900
Compounds: 284
核苷类化合物库
L1720
Compounds: 337
生物碱类天然产物库
L6110
Compounds: 468
肠道微生物代谢化合物库
L2540
Compounds: 352
神经再生化合物库
L7700
Compounds: 529
血管生成库
L4800
Compounds: 1370
氧化还原化合物库
L2900
Compounds: 1279
抗感染化合物库
L1800
Compounds: 2977
免疫/炎症分子化合物库
L4700
Compounds: 3483
FDA 上市激酶抑制剂库
L1610
Compounds: 280
细胞凋亡化合物库
L9000
Compounds: 1796
表型筛选靶点鉴定库
L9500
Compounds: 1832
抗病毒中药单体化合物库
L6730
Compounds: 270
微管靶向化合物库
L1110
Compounds: 80
抗真菌库
L4500
Compounds: 253
泛素化化合物库
L8600
Compounds: 214
NF-κB 通路分子库
L3800
Compounds: 560
抗抑郁症化合物库
L9860
Compounds: 1181
5-羟色胺分子库
L2800
Compounds: 275
抗帕金森病化合物库
L9830
Compounds: 908
细胞重编程化合物库
L8110
Compounds: 1840
Wnt/Hedgehog/Notch 通路化合物库
L4300
Compounds: 240
Ro5类药天然产物库
L6160
Compounds: 2743
抗生素库
L4400
Compounds: 708
甲基化化合物库
L3510
Compounds: 131
PPI抑制剂库
L9400
Compounds: 260
肿瘤免疫治疗小分子化合物库
L2170
Compounds: 454
抗肝癌化合物库
L2193
Compounds: 1816
细胞焦亡化合物库
L8720
Compounds: 1077
多肽分子库
L9600
Compounds: 533
核受体化合物库
L1510
Compounds: 420
谷氨酰胺代谢化合物库
L2550
Compounds: 580
中药抗炎分子库
L6710
Compounds: 1260
萜类天然产物库
L6130
Compounds: 349
抗结直肠癌化合物库
L2194
Compounds: 1565
糖类及苷类化合物库
L6140
Compounds: 364
表观遗传库
L1200
Compounds: 960
GPCR库Plus
L1580
Compounds: 338
人代谢物化合物库
L2570
Compounds: 4532
GPCR靶点分子库
L1500
Compounds: 1633
天然产物单体化合物库
L6020
Compounds: 0
AMPK靶向分子库
L1120
Compounds: 64
中国药典收录天然产物库
L6800
Compounds: 2070
趋化因子抑制剂库
L7600
Compounds: 59
外泌体相关化合物库
L9420
Compounds: 54
抗纤维化化合物库
L9810
Compounds: 1180
内分泌激素分子库
L2400
Compounds: 813
抗寄生虫天然产物库
L6620
Compounds: 233
瑶药化合物库
L6200
Compounds: 225
可溶性羧酸片段化合物库
L7870
Compounds: 1807
天然产物共价化合物库
L6150
Compounds: 596
高溶解性3D结构多样性片段化合物库
L7850
Compounds: 1081
抗结直肠癌中药单体化合物库
L6740
Compounds: 386
共价抑制剂库
L9410
Compounds: 941
染色质修饰分子库
L8300
Compounds: 256
TGF-β/Smad靶点化合物库
L4100
Compounds: 180
JAK-STAT 化合物库
L3700
Compounds: 256
蒙药化合物库
L6220
Compounds: 960
高通量筛选天然产物库
L6000
Compounds: 4320
肾上腺素能受体化合物库
L2700
Compounds: 219
抗感染天然产物库
L6610
Compounds: 1070
钙通道分子库
L7200
Compounds: 143
人内源代谢化合物库
L2500
Compounds: 1400
抗糖尿病库
L1900
Compounds: 690
糖代谢化合物库
L2520
Compounds: 708
抗COVID-19中药单体库
L6720
Compounds: 1162
精选片段库
L5700
Compounds: 246
毒性化合物库
L5500
Compounds: 277
转录因子库
L1380
Compounds: 704
抗肥胖化合物库
L7100
Compounds: 1359
抗病毒库
L1700
Compounds: 800
酪氨酸激酶分子库
L2200
Compounds: 746
组蛋白修饰化合物库
L3500
Compounds: 362
环肽库
L9610
Compounds: 58
海洋天然产物库
L6400
Compounds: 94
MAPK 抑制剂库
L1400
Compounds: 367
抗COVID-19化合物库
L1710
Compounds: 1160
离子通道库
L2300
Compounds: 946
抗癌活性化合物库
L2160
Compounds: 2439
细胞因子抑制剂库
L3600
Compounds: 613
抗癌药物库
L2150
Compounds: 2900
活性脂质化合物库
L7000
Compounds: 385
铁死亡化合物库
L8700
Compounds: 800
细胞周期化合物库
L8100
Compounds: 695
抗衰老化合物库
L8200
Compounds: 3324
药物片段库
L8800
Compounds: 1158
抗癌上市药物库
L2110
Compounds: 1806
血脑屏障通透化合物库
L5900
Compounds: 516
藏药化合物库
L6210
Compounds: 754
抗肿瘤库Plus
L2180
Compounds: 1468
蛋白酶抑制剂库
L1100
Compounds: 344
成骨分子库
L7900
Compounds: 320
抗阿尔茨海默症化合物库
L9840
Compounds: 1040
Cat. No. Product Name Form Specificity Of Inhibition
C0045 RIPA Lysis Buffer (Strong)

RIPA Lysis Buffer (Strong)

C0004 Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)

磷酸酶抑制剂 Cocktail III

2 Tube Solution (100×) Each Tube has different specificity of inhibition
C0003 Phosphatase Inhibitor Cocktail II (100× DMSO)

磷酸酶抑制剂 Cocktail II

Solution (100× in DMSO) Alkaline phosphatases, Ser/Thr phosphatases, Acid and PP1 and PP2A
C0002 Phosphatase Inhibitor Cocktail I (100× ddH2O)

磷酸酶抑制剂 Cocktail I

Solution (100× in ddH2O) Acid Phosphatase, Alkaline phosphatase, PTPs, ATPases
C0001 Protease Inhibitor Cocktail

蛋白酶抑制剂 Cocktail

Solution (EDTA-Free,100× in DMSO) Serine proteases, Aminopeptidases, Cysteine proteases, Aspartic proteases
C0005 Cell Counting Kit-8 (CCK-8)

Cell Counting Kit-8 (CCK-8)

Solution in bottle

TargetMol 试剂盒

RIPA Lysis Buffer (Strong)
C0045
磷酸酶抑制剂 Cocktail III
C0004
磷酸酶抑制剂 Cocktail II
C0003
磷酸酶抑制剂 Cocktail I
C0002
蛋白酶抑制剂 Cocktail
C0001
Cell Counting Kit-8 (CCK-8)
C0005
Cat. No. Product Name Target Signaling Pathways
T14455 Azido-PEG5-Ala-Ala-Asn-PAB

Others Others
Azido-PEG5-Ala-Ala-Asn-PAB is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].

化合物

Azido-PEG5-Ala-Ala-Asn-PAB
T14455
synonym:
Target: Others